Enter your search terms:
Top

Uncategorized

MonoSol Rx Aligns Executive Leadership to Maximize Growth Opportunities, Operational Excellence and R&D Pipeline

Mark Schobel, CEO, Assumes Added Role of Chief Technology Officer; Keith Kendall, CFO, Named Chief Operating Officer Schobel and Kendall to Serve as Co-Presidents Warren, NJ (June 23, 2011) – MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, announced today...

MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone Sublingual Film for Treatment of Opioid Dependence

Second FDA-Approval Drug Based on MonoSol Rx's PharmFilm® Technology; First Sublingually-Administered Prescription Film Product Warren, NJ (August 31, 2010) – MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in film pharmaceutical products, today announced that its partner, Reckitt Benckiser Pharmaceuticals Inc., a wholly-owned subsidiary of...

MonoSol Rx Announces FDA Approval of ZuplenzB. Oral Soluble Film for Treatment of Nausea and Vomiting

First NDA Approval Based on PharmFilm® Technology First FDA Approval for a Prescription Oral Soluble Film for Prevention of Chemotherapy-induced, Radiotherapy-induced, and Postoperative Nausea and Vomiting Warren, NJ, and Balerna, Switzerland (July 7, 2010) – MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in film pharmaceutical...